Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;4(2):89-96.

Local control of brain metastases after stereotactic radiosurgery: the impact of whole brain radiotherapy and treatment paradigm

Affiliations

Local control of brain metastases after stereotactic radiosurgery: the impact of whole brain radiotherapy and treatment paradigm

Ryan T Hughes et al. J Radiosurg SBRT. 2016.

Abstract

Purpose: We investigate clinical, pathologic, and treatment paradigm-related factors affecting local control of brain metastases after stereotactic radiosurgery (SRS) with or without whole brain radiotherapy (WBRT).

Methods and materials: Patients with brain metastases treated with SRS alone, before or after WBRT were considered to determine predictors of local failure (LF), time to failure and survival.

Results: Among 137 patients, 411 brain metastases were analyzed. 23% of patients received SRS alone, 51% received WBRT prior to SRS, and 26% received SRS followed by WBRT. LF occurred in 125 metastases: 63% after SRS alone, 20% after WBRT then SRS, and 22% after SRS then WBRT. Median time to local failure was significantly less after SRS alone compared to WBRT then SRS (12.1 v. 22.7 months, p=0.003). Tumor volume was significantly associated with LF (HR:5.2, p<0.001, 95% CI:3.4-7.8).

Conclusions: WBRT+SRS results in reduced LF. Local control was not significantly different after SRS as salvage therapy versus upfront SRS.

Keywords: brain metastasis; local failure; salvage therapy; stereotactic radiosurgery; treatment paradigm; whole brain radiotherapy.

PubMed Disclaimer

Conflict of interest statement

Authors’ disclosure of potential conflicts of interest The authors reported no conflict of interest.

Figures

Figure 1
Figure 1
Time to local failure by treatment paradigm. Blue: SRS alone, Yellow: WBRT then SRS, Red: SRS then WBRT
Figure 2
Figure 2
Time to local failure by indication for SRS. Blue: SRS alone, Yellow: WBRT local failure salvage, Red: WBRT distant failure salvage, Green: Other.

References

    1. Andrews D.W., et al. , Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet, 2004. 363(9422): p. 1665-72. - PubMed
    1. Aoyama H., et al. , Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA, 2006. 295(21): p. 2483-91. - PubMed
    1. Chang E.L., et al. , Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol, 2009. 10(11): p. 1037-44. - PubMed
    1. Soffietti R., et al. , A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol, 2013. 31(1): p. 65-72. - PubMed
    1. Kocher M., et al. , Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol, 2011. 29(2): p. 134-41. - PMC - PubMed